| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/16/2011 | EP2295065A1 Modified heat shock protein-antigenic peptide complex |
| 03/16/2011 | EP2295064A1 Monoclonal antibody therapy for pancreas cancer |
| 03/16/2011 | EP2295057A1 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 03/16/2011 | EP2295056A1 Use of SNS-595 for treating leukemia |
| 03/16/2011 | EP2295055A2 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof |
| 03/16/2011 | EP2295053A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses |
| 03/16/2011 | EP2294918A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/16/2011 | EP2294186A2 Inducing cell death by inhibiting adaptive heat shock response |
| 03/16/2011 | EP2294072A1 Triazine compounds as p13 kinase and mtor inhibitors |
| 03/16/2011 | EP2294070A1 New phenanthrylphenol linked pyrrolo[2,l-c][l,4]benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof |
| 03/16/2011 | EP2294065A1 Indolyl- pyridone derivatives having checkpoint kinase 1 inhibitory activity |
| 03/16/2011 | EP2294062A1 Substituted 4- (indazolyl) -1,4-dihydropyridines and methods of use thereof |
| 03/16/2011 | EP2294061A2 Disubstituted phthalazine hedgehog pathway antagonists |
| 03/16/2011 | EP2293847A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293846A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293845A1 Depsipeptides and their therapeutic use |
| 03/16/2011 | EP2293807A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 03/16/2011 | EP2293798A1 Pregesteron antagonists such as cdb-4124 in the treatment of breast cancer |
| 03/16/2011 | EP2293797A1 Pregesterone antagonists such as cdb-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc |
| 03/16/2011 | EP2293795A1 Pharmaceutical combination |
| 03/16/2011 | EP2097453B1 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 03/16/2011 | EP2057165B1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 03/16/2011 | EP2046758B1 Substituted sulphoximines as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/16/2011 | EP2025661B1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof |
| 03/16/2011 | EP1940846B1 Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2a]pyrazin-1-one compounds |
| 03/16/2011 | EP1897884B1 Physiologically active substance nk13650p3, method of producing the same and use thereof |
| 03/16/2011 | EP1879856B1 Alkyl-, alkenyl- and alkynyl carbamate derivatives, the preparation and therapeutic use thereof |
| 03/16/2011 | EP1877428B1 Cyanine- chlorotoxin conjugate and method for intra-operative visualization of cancer |
| 03/16/2011 | EP1495018B3 Tricyclic thrombin receptor antagonists |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | EP1412388B1 Humanized antibodies derived from dd-3b6/22, specific for the d-dimer fragment of fibrin |
| 03/16/2011 | EP1383785B1 Recombinant tumor specific antibody and use thereof |
| 03/16/2011 | EP1344777B1 Imidazole derivatives, process for their preparation and their use |
| 03/16/2011 | EP1326633B1 Composition comprising immunogenic microparticles |
| 03/16/2011 | EP1298137B1 Novel substance having physiological activity, process for producing the same, and use |
| 03/16/2011 | CN1917867B Compounds having antitumor activity |
| 03/16/2011 | CN1769433B Recombinant vesicular stomatitis virus and its uses |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985483A Iodinated PRTH, and preparation method and application thereof |
| 03/16/2011 | CN101985471A Folate-IgG conjugate as well as preparation method and application thereof |
| 03/16/2011 | CN101985457A Medicinal salts of cordycepin and preparation method and medicinal application thereof |
| 03/16/2011 | CN101985449A Coumarin derivative, and preparation method and use thereof as anti-cancer medicament |
| 03/16/2011 | CN101985432A 3-Fmoc amino-3-(3-nitro-4-fluophenyl) propionic acid and preparation method thereof |
| 03/16/2011 | CN101985428A O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof |
| 03/16/2011 | CN101985037A Applications of receptor for activated C-kinase 1 as target against tumor drug-resistance |
| 03/16/2011 | CN101985033A Compound traditional Chinese medicine for treating stubborn diseases |
| 03/16/2011 | CN101985002A Medicinal composition for treating cancer |
| 03/16/2011 | CN101984997A Anti-tumor composition containing four-substance decoction extract and application thereof |
| 03/16/2011 | CN101984975A Medical composition containing cordycepin derivatives |
| 03/16/2011 | CN101984973A Medicinal application of 20(R)-25-methoxyl-dammarane-3 beta,12 beta,20-triol |
| 03/16/2011 | CN101984968A Preparation method of pharmaceutical preparation of antitumor agent temozolomide |
| 03/16/2011 | CN101984967A Manganoporphyrin-dichloroacetic acid combined medicament for treating tumors |
| 03/16/2011 | CN101984964A Application of T-2 toxin to preparing drugs for treating renal cell carcinomas |
| 03/16/2011 | CN101984963A Application of T-2 toxin to preparing drugs for treating pancreatic carcinoma |
| 03/16/2011 | CN101984962A Application of T-2 toxin to preparing drugs for treating brain tumors |
| 03/16/2011 | CN101984961A Furanodiene-containing medicinal composition, technology for preparing preparation thereof and medicinal use thereof |
| 03/16/2011 | CN101984956A Application of pH sensitive type amphiphilic graft polyphosphazene for preparing administration vesicle |
| 03/16/2011 | CN101700356B Traditional Chinese medicine composition for treating breast cancer |
| 03/16/2011 | CN101642453B Medicinal preparation comprising Epothilone B |
| 03/16/2011 | CN101590186B Chinese medicinal composition for thoroughly eliminating hysteromyoma |
| 03/16/2011 | CN101537061B Chinese medicine for treating liver cancer |
| 03/16/2011 | CN101530490B Traditional Chinese medicine for treating bladder cancer |
| 03/16/2011 | CN101530436B Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 03/16/2011 | CN101519424B Acanthopanaxgenin acid with antitumor and antiangiogenic activities |
| 03/16/2011 | CN101507742B Tridax procumbens total flavone preparation method and use thereof |
| 03/16/2011 | CN101475651B Preparation of Gracilaria gigas Harvey polysaccharides |
| 03/16/2011 | CN101475648B Preparation of Mallotus furetianus polysaccharide |
| 03/16/2011 | CN101433564B Use of water chestnut extract in preparing medicament for treating leukaemia |
| 03/16/2011 | CN101407815B Use of glycine-N-methyltransferase (GNMT) in preparing medicine for preventing and treating disease derived from flavacin |
| 03/16/2011 | CN101401786B Nelarabine injection |
| 03/16/2011 | CN101284052B Chinese medicinal materials compound prescription for treating the tumor |
| 03/16/2011 | CN101181516B Chinese medicine prescription orally taken for curing leukaemia |
| 03/16/2011 | CN101156884B A preparation method of new type anticancer compound recipe medicine |
| 03/16/2011 | CN101036732B Chinese medicine preparation for esophagus cancer and its compounding process |
| 03/16/2011 | CN101007110B An antitumor medicine and its preparation method |
| 03/16/2011 | CN100999503B Hexanary carbocycle azole like nucleoside analogue, its synthesizing process and use in anti virus and tumor thereof |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906557 Oral preventive/therapeutic agent for skin damage containing diacylglyceryl ether |
| 03/15/2011 | US7906554 Combination chemotherapy compositions and methods |
| 03/15/2011 | US7906545 Prodrugs of CC-1065 analogs |
| 03/15/2011 | US7906523 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 03/15/2011 | US7906516 Carbonyl compounds |
| 03/15/2011 | US7906491 Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs) |
| 03/15/2011 | US7906329 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery |
| 03/15/2011 | US7906139 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 03/15/2011 | CA2675757C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 03/15/2011 | CA2502769C 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 03/15/2011 | CA2494063C Inhibition of proliferation and infiltration of brain tumor cells caused by expression of ampa-type glutamate receptor subunit |
| 03/15/2011 | CA2480708C Method and dietary composition for improving fat digestibility |
| 03/15/2011 | CA2477774C Indolylmaleimide derivatives |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |
| 03/15/2011 | CA2470703C Oral pharmaceutical products containing 17.beta.-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 03/15/2011 | CA2470423C Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 03/15/2011 | CA2462228C 4-(c2-6alkoxy)-substituted chalcones as therapeutic agents |
| 03/15/2011 | CA2458318C Wortmannin analogs and methods of using same |
| 03/15/2011 | CA2458266C Substituted urea retinoid agonists ii |
| 03/15/2011 | CA2451230C Eurotinones, and derivatives thereof, processes for preparing them, and their use |
| 03/15/2011 | CA2432000C Pyrimidineamines as angiogenesis modulators |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |